Voyageur Pharmaceuticals's total assets for Q2 2025 were C$2.95M, a decrease of -6.56% from the previous quarter. VYYRF total liabilities were C$2.04M for the fiscal quarter, a 3.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.